Abstract 2903: Evaluation of SMP-3124, a novel liposome-encapsulated CHK1 inhibitor, in patient-derived preclinical models of treatment-resistant ovarian cancer

Authors: Yuka Kumagai, Junzo Hamanishi, Ryusuke Murakami, Kana Shimizu, Yosuke Ota, Yusuke Sawayama, Naoaki Shimada, Kento Hayashi, Yoshiko Fukuoka, Steven L. Warner, Jason M. Foulks, Masaki Mandai, Makoto Matsuoka, Seiji Kamioka, Hitoshi Ban, Hiroki Umehara

Published: 2025-04-21

DOI: 10.1158/1538-7445.am2025-2903

Source: Full article